BCL2 and acute myeloid leukemia: B-cell lymphoma 2 (Bcl-2), an apoptosis suppressor gene, is highly expressed in the bone marrow of AML patients.12 The overexpression of Bcl-2 induces resistance to chemotherapy drugs in AML cells,13 thus leading to poor prognosis, such as relapse in AML.14